CREATION AND PHARMACOTECHNOLOGICAL INVESTIGATIONS OF INNOVATIVE DOSAGE FORMS OF MEXIDOL
Abstract
The present study is devoted to the creation and study of transdermal dosage forms with mexidol and experimental substantiation of their therapeutic efficacy. The original technological scheme of production of one of the most popular structures transdermal - transdermal patches with mexidol. Selected efficient packaging, a shelf life of dosage forms. Developed, justified, biopharmaceutical research confirmed the optimal composition cohesive mass. Conducted optimal standardization of patches according to the most characteristic and important indicators. Studied local irritating effect and hipersensitivity proposed dosage form. Investigated and confirmed the ability of transdermal forms of mexidol to percutaneous transport.
About the Authors
E. F. Stepanova
Pyatigorsk Medical and Pharmaceutical Institute - a branch of Volgograd State Medical University of the Ministry of Healthcare
Russian Federation
Russian Federation
S. O. Losenkova
Smolensk State Medical University of the Ministry of Healthcare
Russian Federation
Russian Federation
Yu. A. Morozov
North Ossetian State University named after Kosta Levanovich Khetagurov
Russian Federation
Russian Federation
References
1. Petrov V. I. Cluster approach in creating innovative medicines // Economic and humanitarian studies of regions. 2012. № 5. S. 6-14.
2. Sampiev A. M., Nikiforova E. B., Davitavyan N. A. Modern achievements in the development and application of innovative medicines // New technologies. 2012. № 2. S. 247-254.
3. Beregovykh V. V., Pyatigorskaya N. V., Prudkevich Yu. A. Transdermal therapeutic drug delivery systems // Vestnik MIHTKh. 2012. T. 7. № 5. S. 17-22.
4. Erofeeva S. B. Place mexidol in the prevention and treatment of cerebrovascular diseases // Pharmateka. 2009. № 11. S. 34-38.
5. Государственный реестр лекарственных средств. - М., 2018. URL: http://grls.rosminzdrav.ru/grls.aspx (дата обращения 28.02.18).
6. Bykov V. A., Alekseev M. V., Vorotnikov A. I. Current state and Perspectivities for the creation of new aesthetic, aroma and phytotherapeutic transdermal cosmetic products (Review) // Questions of Biological, Medical and Pharmaceutical Chemistry. 2012. № 1(10). S. 122-134.
7. Morina E. A. Development of transdermal dosage forms of flavolignans: author’s abstract. dis. ... Ph.D. - M., 2010. 23 s.
8. Lutsenko S. V., Fel’dman N. B., Lutsenko E. V., Bykov V. A. Plant flavolignanes. Biological activity and therapeutic potential. - M., 2006. 235 s.
9. Mizina P. G. Theoretical and experimental substantiation of the creation of application medicinal forms on the basis of plant phenylpropanoids // Pharmacia. 2003. № 3. S. 36.
10. Morozov Yu. A. A study of the ability of Chinese magnolia lignans to percutaneous permeability in an experiment // Medical Bulletin of Bashkortostan. 2016. № 11(2-62). S. 58-62.
11. Makieva M. S., Morozov Yu. A., Voronkov A. V. i dr. Development of a transdermal gel with Schisandra oil chineseevaluation of the degree of its impact on performance and neurological the status of animals in the experiment, // Medical Gazette of the North Caucasus. 2016. № 4(11). S. 532-536.
12. Losenkova S. O., Stepanova E. F., Novikov V. E. Features of the methodology of biopharmaceutical research of the transdermal patch with mexidol // Bulletin of the Voronezh State University. Series: Chemistry, Biology, Pharmacy. 2009. № 1. S.113-116.
13. Losenkova S. O., Stepanova E. F., Novikov V. E. Biopharmaceutical studies in vitro of transdermal patches with mexidol // KursThe scientific and practical bulletin «The Man and His Health». 2010. № 1. S. 117-122.
14. Losenkova S. O., Pogrebnyak A. V., Morozov Yu. A. i dr. Computer modeling as one of the modern methods of forecasting in pharmaceutical technology // Pharmacy and Pharmacology. 2014. № 6(7). S. 105-113.
15. Патент РФ 1459215, МКИ C08L 39/06, A61K 31/79. Состав полимерной диффузионной матрицы для трансдермального введения лекарственных веществ / Васильев А. Е. и др. - № 4189829/05; заявл. 20.12.86; опубл. 20.11.95, Бюл. № 52. 18 с.
16. Vasil’ev A. E., Krasnyuk I. I., Ravikumar S. i dr. Transdermal therapeutic drug delivery systems (Review) // Chemical-pharmaceutical journal. 2001. T. 36. № 11. S. 29-42.
17. Maksimenko O. O., Ravikumar S., Andreev S. M. i dr. Stability of transdermal therapeutic systems with indomethacin // Chemical-Pharmaceutical Journal. 2001. T. 35. № 10. S. 53-55.
18. Pogorel’tsev V. I., Garmonov S. Yu., Evgen’ev M. I. Farmakokinetika ksimedona // Khimiko-farmatsevticheskii zhurnal. Pharmacokinetics of xymedon // Chemical-Pharmaceutical Journal. 2006. T. 40. № 7. S. 5-8.
19. Alekseeva O. G., Petkevich A. I. To the technique for determining the allergenic properties of chemical substances // Hygiene and Sanitation. 1972. № 3. S. 64-67.
Review
For citations:
Stepanova E.F., Losenkova S.O., Morozov Yu.A. CREATION AND PHARMACOTECHNOLOGICAL INVESTIGATIONS OF INNOVATIVE DOSAGE FORMS OF MEXIDOL. Drug development & registration. 2018;(4):37-43. (In Russ.)
Views:
969
Email this article 